Drug news
Architect HbA1c test to diagnose Diabetes receives 510(k) approval in US - Abbott Diagnostics
Abbott has announced that its new ARCHITECT Clinical Chemistry Hemoglobin A1c (HbA1c) test � which can aid physicians in diagnosing and monitoring Diabetes and identifying people at risk for the disease � has received 510(k) clearance from the FDA.
The clinical chemistry Hemoglobin A1c (HbA1c) test already has CE Mark conformity.